MBD3L3
gene geneOn this page
Summary
MBD3L3 (methyl-CpG binding domain protein 3 like 3, HGNC:37205) is a protein-coding gene on chromosome 19p13.2, encoding Methyl-CpG-binding domain protein 3-like 3 (A6NE82).
Predicted to enable methyl-CpG binding activity. Predicted to be involved in DNA methylation-dependent constitutive heterochromatin formation and negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 653657 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001164425
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37205 |
| Approved symbol | MBD3L3 |
| Name | methyl-CpG binding domain protein 3 like 3 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000182315 |
| Ensembl biotype | protein_coding |
| Entrez | 653657 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000333843, ENST00000689071, ENST00000693237
RefSeq mRNA: 1 — MANE Select: NM_001164425
NM_001164425
CCDS: CCDS45944
Canonical transcript exons
ENST00000333843 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001592667 | 7056207 | 7056903 |
| ENSE00001694235 | 7058561 | 7058676 |
Expression profiles
Bgee: expression breadth tissue_specific, 10 present calls, max score 93.22.
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.22 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.38 | gold quality |
| left testis | UBERON:0004533 | 38.81 | gold quality |
| granulocyte | CL:0000094 | 38.37 | gold quality |
| bone marrow cell | CL:0002092 | 38.30 | gold quality |
| testis | UBERON:0000473 | 38.08 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.14 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| right testis | UBERON:0004534 | 35.95 | gold quality |
| bone marrow | UBERON:0002371 | 34.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.24 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 28.53 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| leukocyte | CL:0000738 | 27.95 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| monocyte | CL:0000576 | 27.31 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.30 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.28 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.99 | gold quality |
| frontal cortex | UBERON:0001870 | 26.81 | gold quality |
| urinary bladder | UBERON:0001255 | 26.61 | gold quality |
| endocervix | UBERON:0000458 | 26.43 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-3929 | yes | 4618.75 |
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting MBD3L3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-7515 | 99.31 | 68.22 | 1795 |
| HSA-MIR-491-5P | 99.13 | 65.98 | 1468 |
| HSA-MIR-4504 | 99.10 | 69.14 | 1328 |
| HSA-MIR-3945 | 98.68 | 64.21 | 553 |
| HSA-MIR-595 | 98.25 | 67.44 | 699 |
| HSA-MIR-5681A | 97.99 | 67.17 | 1658 |
| HSA-MIR-4253 | 97.48 | 65.11 | 692 |
| HSA-MIR-6862-5P | 97.48 | 64.84 | 713 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mbd3a | ENSDARG00000061774 |
| mus_musculus | Mbd3l2 | ENSMUSG00000047508 |
| rattus_norvegicus | Mbd3l2 | ENSRNOG00000026629 |
| rattus_norvegicus | Mbd3l3 | ENSRNOG00000065634 |
| drosophila_melanogaster | MBD-like | FBGN0027950 |
Paralogs (8): MBD3 (ENSG00000071655), MBD2 (ENSG00000134046), MBD1 (ENSG00000141644), MBD3L1 (ENSG00000170948), MBD3L2B (ENSG00000196589), MBD3L4 (ENSG00000205718), MBD3L2 (ENSG00000230522), MBD3L5 (ENSG00000237247)
Protein
Protein identifiers
Methyl-CpG-binding domain protein 3-like 3 — A6NE82 (reviewed: A6NE82)
All UniProt accessions (1): A6NE82
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. The MBD3L proteins are encoded by strongly repeated regions of the 19p13 chromosome. The exact number of functional copies is unclear, and some of them may represent pseudogenes.
Similarity. Belongs to the MBD3L family.
RefSeq proteins (1): NP_001157897* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025884 | MeCpG-bd_2/3_C_dom | Domain |
| IPR032343 | MBD2/MBD3_p55-bd | Domain |
Pfam: PF14048, PF16564
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NE82-F1 | 66.82 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, GOBP_DNA_METHYLATION_DEPENDENT_CONSTITUTIVE_HETEROCHROMATIN_FORMATION, GOBP_CHROMATIN_REMODELING, GOBP_HETEROCHROMATIN_ORGANIZATION, GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, chr19p13, GOMF_METHYL_CPG_BINDING, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, MIR92A_2_5P, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION, GOBP_CONSTITUTIVE_HETEROCHROMATIN_FORMATION, GOBP_CHROMATIN_ORGANIZATION, GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS
GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), DNA methylation-dependent constitutive heterochromatin formation (GO:0006346)
GO Molecular Function (2): methyl-CpG binding (GO:0008327), protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| constitutive heterochromatin formation | 1 |
| nucleotide binding | 1 |
| sequence-specific DNA binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
258 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MBD3L3 | LEUTX | A8MZ59 | 580 |
| MBD3L3 | PRAMEF15 | P0DUQ1 | 571 |
| MBD3L3 | PRAMEF25 | A6NGN4 | 540 |
| MBD3L3 | TRIM49 | P0CI25 | 513 |
| MBD3L3 | A0A096LNW4 | A0A096LNW4 | 507 |
| MBD3L3 | DUXA | A6NLW8 | 507 |
| MBD3L3 | OR4F17 | Q8NGA8 | 507 |
| MBD3L3 | DUXB | A0A1W2PPF3 | 503 |
| MBD3L3 | H3Y1 | P0DPK2 | 496 |
| MBD3L3 | TRIM43 | Q96BQ3 | 480 |
| MBD3L3 | ZSCAN4 | Q8NAM6 | 480 |
| MBD3L3 | TRIM43B | A6NCK2 | 447 |
| MBD3L3 | RFPL4B | Q6ZWI9 | 446 |
| MBD3L3 | H3Y2 | P0DPK5 | 437 |
| MBD3L3 | ZNF566 | Q969W8 | 431 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MBD3L3 | TRIML2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBD3L3 | TRIML2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): MBD3L3 (Two-hybrid)
ESM2 similar proteins: A0A1B0GVZ6, A5D7I0, A6H7B4, A6NDZ8, A6NE82, A6NJ08, A6NJB7, A6NJI1, A6NL46, A6QP24, A8MUA0, A8MUI8, A8MV72, A8MX80, B2RW88, O94850, P0C6A0, P24097, P50617, Q0P5M0, Q0VD86, Q2KIL8, Q3B8N5, Q3SY00, Q3SYA9, Q3UN58, Q5BMD4, Q5JTZ5, Q5RBE4, Q5VZ46, Q66MI6, Q68US1, Q6GQV0, Q6PAC4, Q80TS7, Q80VY2, Q8BFY7, Q8BII1, Q8IXW0, Q8K2F3
Diamond homologs: A0A1B0GVZ6, A6NDZ8, A6NE82, A6NJ08, O95983, Q8NHZ7, Q8WWY6, Q9D9H3, Q9UBB5, Q9Z2D8, Q9Z2E1, O95243, P51608, Q00566, Q95LG8, Q9UIS9, Q9Z2D6, Q9Z2D7, Q9Z2E2, Q9FZP6, Q9LTJ1, Q9LYB9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
80 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:7056899:TTCCC:T | acceptor_gain | 1.0000 |
| 19:7056901:CCC:C | acceptor_gain | 1.0000 |
| 19:7056902:CCC:C | acceptor_gain | 1.0000 |
| 19:7056903:CCT:C | acceptor_gain | 1.0000 |
| 19:7056904:C:CC | acceptor_gain | 1.0000 |
| 19:7056905:T:C | acceptor_gain | 1.0000 |
| 19:7056908:C:CT | acceptor_gain | 1.0000 |
| 19:7056909:A:T | acceptor_gain | 1.0000 |
| 19:7058557:TCA:T | donor_loss | 1.0000 |
| 19:7058558:CACCA:C | donor_loss | 1.0000 |
| 19:7058559:A:AC | donor_gain | 1.0000 |
| 19:7058559:ACCAG:A | donor_loss | 1.0000 |
| 19:7058560:C:CG | donor_loss | 1.0000 |
| 19:7058560:C:CT | donor_gain | 1.0000 |
| 19:7056901:CCCCT:C | acceptor_gain | 0.9900 |
| 19:7056902:CC:C | acceptor_gain | 0.9900 |
| 19:7056904:C:T | acceptor_gain | 0.9900 |
| 19:7056905:T:TC | acceptor_gain | 0.9900 |
| 19:7058555:A:AC | donor_gain | 0.9900 |
| 19:7058556:C:CC | donor_gain | 0.9900 |
| 19:7058556:CTCA:C | donor_gain | 0.9900 |
| 19:7058559:AC:A | donor_gain | 0.9900 |
| 19:7058560:CC:C | donor_gain | 0.9900 |
| 19:7058560:CCAG:C | donor_gain | 0.9900 |
| 19:7058560:CCAGA:C | donor_gain | 0.9900 |
| 19:7056900:TCCC:T | acceptor_gain | 0.9800 |
| 19:7058556:CT:C | donor_gain | 0.9700 |
| 19:7058560:CCA:C | donor_gain | 0.9700 |
| 19:7056900:TCCCC:T | acceptor_gain | 0.9500 |
| 19:7056906:T:TC | acceptor_gain | 0.9500 |
AlphaMissense
1337 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:7056778:G:C | F57L | 0.947 |
| 19:7056778:G:T | F57L | 0.947 |
| 19:7056780:A:G | F57L | 0.947 |
| 19:7056787:G:C | S54R | 0.916 |
| 19:7056787:G:T | S54R | 0.916 |
| 19:7056789:T:G | S54R | 0.916 |
| 19:7056391:C:A | R186S | 0.898 |
| 19:7056391:C:G | R186S | 0.898 |
| 19:7056791:G:A | T53I | 0.887 |
| 19:7056415:C:A | Q178H | 0.874 |
| 19:7056415:C:G | Q178H | 0.874 |
| 19:7056779:A:G | F57S | 0.866 |
| 19:7056764:G:A | T62I | 0.855 |
| 19:7056392:C:A | R186M | 0.843 |
| 19:7056758:A:G | I64T | 0.842 |
| 19:7056782:A:G | I56T | 0.832 |
| 19:7056796:T:A | R51S | 0.824 |
| 19:7056796:T:G | R51S | 0.824 |
| 19:7056375:C:G | A192P | 0.809 |
| 19:7056779:A:C | F57C | 0.808 |
| 19:7056881:A:G | M23T | 0.806 |
| 19:7056396:C:G | A185P | 0.803 |
| 19:7056788:C:A | S54I | 0.797 |
| 19:7056425:A:G | I175T | 0.791 |
| 19:7056371:A:G | L193S | 0.781 |
| 19:7056392:C:G | R186T | 0.777 |
| 19:7056440:A:T | V170E | 0.775 |
| 19:7056691:T:A | Q86H | 0.769 |
| 19:7056691:T:G | Q86H | 0.769 |
| 19:7056786:A:G | C55R | 0.765 |
dbSNP variants (sampled 300 via entrez): RS1002081621 (19:7056684 C>T), RS1002711986 (19:7055876 C>T), RS1002733154 (19:7055737 C>G,T), RS1003469872 (19:7058474 A>G), RS1005935452 (19:7060454 T>A), RS1006970306 (19:7056022 G>A,C,T), RS1010686627 (19:7056654 A>G), RS1011072542 (19:7056270 A>G), RS1012042347 (19:7055716 G>A), RS1014511248 (19:7056770 G>A,C), RS1014543743 (19:7060343 T>A), RS1017025852 (19:7060457 A>G,T), RS1017978500 (19:7056030 A>G,T), RS1018448564 (19:7055920 C>A), RS1021282934 (19:7059836 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium | decreases expression, increases abundance | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.